IDH-mutant gliomas have a significantly lower ASL and DSC tumor perfusion compared to IDH-wildtype, whereas pTERT-mutant gliomas show significantly higher ASL and DSC perfusion in tumor and edema compared to pTERT-wildtype. This evidence concerns the gene IDH2 and neoplasm.